126650DL1 Competition
| 126650DL1 | 83.38 7.71 10.19% |
126650DL1 |
126650DL1 Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between 126650DL1 and its competitors represents the degree of relationship between the price movements of corresponding bonds. A correlation of about +1.0 implies that the price of 126650DL1 and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of CVS HEALTH P does not affect the price movement of the other competitor.
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between 126650DL1 Bond performing well and 126650DL1 Corporate Bond doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze 126650DL1's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| KO | 0.70 | (0.14) | 0.00 | (1.23) | 0.00 | 1.18 | 4.07 | |||
| JPM | 1.11 | 0.03 | 0.07 | 0.12 | 1.44 | 2.05 | 15.87 | |||
| DD | 0.99 | (0.02) | (0.04) | 0.07 | 1.18 | 2.68 | 7.46 | |||
| AA | 2.48 | 0.34 | 0.15 | 0.26 | 2.65 | 6.10 | 14.99 | |||
| BA | 1.62 | (0.31) | 0.00 | (0.81) | 0.00 | 3.00 | 8.59 | |||
| MSFT | 0.90 | (0.11) | 0.00 | (0.05) | 0.00 | 2.09 | 8.19 | |||
| PG | 0.69 | 0.04 | (0.08) | (0.16) | 0.84 | 1.56 | 4.66 | |||
| IBM | 0.97 | 0.11 | 0.06 | 0.23 | 1.33 | 2.22 | 8.66 |
126650DL1 Competitive Analysis
The better you understand 126650DL1 competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, 126650DL1's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across 126650DL1's competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
126650DL1 Competition Performance Charts
Five steps to successful analysis of 126650DL1 Competition
126650DL1's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by CVS HEALTH P in relation to its competition. 126650DL1's competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of 126650DL1 in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact 126650DL1's competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to CVS HEALTH P, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your 126650DL1 position
In addition to having 126650DL1 in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Chemicals Thematic Idea Now
Chemicals
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Chemicals theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Chemicals Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in 126650DL1 Bond
126650DL1 financial ratios help investors to determine whether 126650DL1 Bond is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in 126650DL1 with respect to the benefits of owning 126650DL1 security.